Alice P. Chen
Impact in
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 84
- PARP inhibition in cancer therapy 47
-
- Cancer Genomics and Diagnostics 26
- Co-authors
- Shivaani Kummar (32 shared papers)James H. Doroshow (36 shared papers)Robert J. Kinders (15 shared papers)Stefan Zeuzem (1 shared paper)Michael R. Hodges (1 shared paper)Arthur Aaron Levin (1 shared paper)Harry L.A. Janssen (1 shared paper)Yi Zhou (1 shared paper)
- Journals
- Clinical Cancer Research (32 papers)Cancer Chemotherapy and Pharmacology (19 papers)Journal of Clinical Oncology (12 papers)Investigational New Drugs (7 papers)Blood (5 papers)
- Partner nations
- United StatesCanadaMalaysia
In The Last Decade
Alice P. Chen
251 papers receiving 14.4k citations
Alice P. Chen's Hit Papers
Peers
Comparison fields: 5 of 173
- Cancer Research 3.1k
- Oncology 5.2k
- Molecular Biology 5.2k
- Pulmonary and Respiratory Medicine 1.9k
- Hepatology 433
Countries citing papers authored by Alice P. Chen
This map shows the geographic impact of Alice P. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice P. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice P. Chen more than expected).
Fields of papers citing papers by Alice P. Chen
This network shows the impact of papers produced by Alice P. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice P. Chen. The network helps show where Alice P. Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Alice P. Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 260 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Treatment of HCV Infection by Targeting MicroRNA Hit paper breakdown → | 2013 | 1859 |
| 2 | RECIST 1.1—Update and clarification: From the RECIST committee Hit paper breakdown → | 2016 | 1475 |
| 3 | 2018 | 335 | |
| 4 | 2020 | 303 | |
| 5 | 2012 | 296 | |
| 6 | 2015 | 283 | |
| 7 | 2016 | 282 | |
| 8 | 2009 | 267 | |
| 9 | 2004 | 252 | |
| 10 | 2020 | 237 | |
| 11 | 2015 | 218 | |
| 12 | 2011 | 216 | |
| 13 | 2020 | 209 | |
| 14 | 2002 | 187 | |
| 15 | 2011 | 187 | |
| 16 | 2012 | 185 | |
| 17 | 2001 | 174 | |
| 18 | 2020 | 160 | |
| 19 | 2017 | 154 | |
| 20 | 2011 | 149 |
About Alice P. Chen
Alice P. Chen is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Genetics, having authored 260 papers that have together received 14.8k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (47 papers), Cancer Genomics and Diagnostics (26 papers), DNA Repair Mechanisms (17 papers), Cancer therapeutics and mechanisms (15 papers), Advanced Optical Network Technologies (10 papers), Lung Cancer Treatments and Mutations (10 papers), Statistical Methods in Clinical Trials (9 papers) and Sarcoma Diagnosis and Treatment (9 papers). The work is most often cited by research in Cancer Research (3.1k citations), Oncology (5.2k citations), Molecular Biology (5.2k citations), Pulmonary and Respiratory Medicine (1.9k citations) and Hepatology (433 citations). Alice P. Chen has collaborated with scholars based in United States, Canada and Malaysia. Frequent co-authors include Shivaani Kummar, James H. Doroshow, Robert J. Kinders, Stefan Zeuzem, Michael R. Hodges, Arthur Aaron Levin, Harry L.A. Janssen, Yi Zhou, Maribel Rodriguez‐Torres and Robert Persson. Their work appears in journals such as Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, Investigational New Drugs and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.